Suchergebnisse - "McInnes, Iain B"

PubPharm (746)

1

Reframing sepsis immunobiology for translation : towards informative subtyping and targeted immunomodulatory therapies

enthalten in: The Lancet. Respiratory medicine | 2024

von Shankar-Hari, M. | Calandra, T. | Soares, M. | +18

2

Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis

enthalten in: Clinical rheumatology | 2024

von Rahman, P. | McInnes, I. | Deodhar, A. | +10

3

Efficacy and safety of pharmacological treatment of psoriatic arthritis : a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis

enthalten in: Annals of the rheumatic diseases | 2024

von Kerschbaumer, A. | Smolen, J. | Ferreira, R. | +11

4

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2023 update

enthalten in: Annals of the rheumatic diseases | 2024

von Gossec, L. | Kerschbaumer, A. | Ferreira, R. | +33

5

Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison

enthalten in: Rheumatology and therapy | 2024

von Warren, R. | McInnes, I. | Nash, P. | +6

6

Unmet need in rheumatology : reports from the Advances in Targeted Therapies meeting, 2023

enthalten in: Annals of the rheumatic diseases | 2024

von Winthrop, K. | Mease, P. | Kerschbaumer, A. | +19

7

Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis

enthalten in: Clinical rheumatology | 2024

von Rahman, P. | McInnes, I. | Deodhar, A. | +10

8

Gout and incidence of 12 cardiovascular diseases : a case-control study including 152 663 individuals with gout and 709 981 matched controls

enthalten in: The Lancet. Rheumatology | 2024

von Ferguson, L. | Molenberghs, G. | Verbeke, G. | +6

9

Work Productivity and General Health Through 2 Years of Guselkumab Treatment in a Phase 3 Randomized Trial of Patients With Active Psoriatic Arthritis

enthalten in: Rheumatology and therapy | 2024

von Curtis, J. | McInnes, I. | Rahman, P. | +10

10

Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison

enthalten in: Rheumatology and therapy | 2024

von Mease, P. | Warren, R. | Nash, P. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[75]